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 2 
 Abstract 1 
 2 
 TrwC is a bacterial protein involved in conjugative transfer of plasmid R388. 3 
It is transferred together with the DNA strand into the recipient bacterial cell, where 4 
it can integrate the conjugatively transferred DNA strand into its target sequence 5 
present in the recipient cell. Considering that bacterial conjugation can occur 6 
between bacteria and eukaryotic cells, this protein has great biotechnological 7 
potential as a site-specific integrase. We have searched for possible TrwC target 8 
sequences in the human genome. Recombination assays showed that TrwC 9 
efficiently catalyzes recombination between its natural target sequence and a 10 
discrete number of sequences, located in non-coding sites of the human genome, 11 
which resemble this target. We have determined the cellular localization of TrwC 12 
and derivatives in human cells by immunofluorescence, and also an indirect yeast-13 
based assay to detect both nuclear import and export signals. The results indicate 14 
that the recombinase domain of TrwC (N600) has nuclear localization, but full-15 
length TrwC locates in the cytoplasm, apparently due to the presence of a nuclear 16 
export signal in its C-terminal domain. The recombinase domain of TrwC can be 17 
transported to recipient cells by conjugation in the presence of the helicase domain 18 
of TrwC, but with very low efficiency. We mutagenized the trwC gene and selected 19 
for mutants with nuclear localization. We obtained one such mutant with a point 20 
A904T mutation and an extra peptide at its C-terminus, which maintained its 21 
functionality in conjugation and recombination. This TrwC mutant could be useful 22 
for future TrwC-mediated site-specific integration assays in mammalian cells.  23 
 24 
 3 
 Introduction 1 
 2 
 Bacterial conjugation is a specialised mechanism to transfer plasmid DNA 3 
from a donor to a recipient bacterial cell. Under laboratory conditions, conjugative 4 
DNA transfer has been described to occur from bacteria to S. cerevisiae (19), plants 5 
(3) and mammalian cells (45). The molecular process is related to the naturally 6 
occurring inter-kingdom gene transfer process from Agrobacterium tumefaciens to 7 
plant cells (47). 8 
 Mechanistically, bacterial conjugation has been described as a two step 9 
process involving conjugative DNA processing followed by active DNA transport 10 
(30). DNA processing is driven by a nucleoprotein complex called relaxosome. 11 
Within it, a relaxase protein introduces a site and strand specific nick into the origin 12 
of transfer (oriT), remaining convalently bond to the 5’ end of the DNA strand to be 13 
transferred. For the DNA transport, a set of proteins constitute a type IV secretion 14 
system (T4SS) that forms a transmembranal channel. Transfer of the DNA molecule 15 
is proposed to occur in two steps: i) the secretion of the relaxase protein (with the 16 
attached DNA strand) through the T4SS, and ii) pumping out of the remaining DNA 17 
molecule by a specialised ATPase (30). Thus, the relaxase also functions as a pilot 18 
protein guiding the DNA molecule into the recipient cell, where it presumably acts 19 
recircularizing the transferred DNA strand (10). 20 
 TrwC is the relaxase of the conjugative system of plasmid R388 (31). Its 21 
966 amino acids comprise several functional domains, as shown in Fig. 1a. The 22 
crystal structure of the N-terminal relaxase domain has been determined (17). It 23 
shares a central structural domain with the HUH family of proteins, which include 24 
the rolling circle replication initiation proteins (5) and the Rep protein of adeno-25 
associated virus (AAV) (21), which catalyses the integration of the viral genome 26 
into a unique site in the human genome (41). The C-terminal domain shows 27 
oligomerization and DNA helicase activities. Both the relaxase and helicase domains 28 
 4 
expressed in the same cell reconstitute TrwC function in conjugation to a certain 1 
extent (32). 2 
 TrwC is also a site-specific recombinase capable of promoting efficient 3 
recombination between two cognate oriTs on a double-stranded (ds) DNA molecule 4 
(28). The relaxosomal component protein TrwA is required for high efficiency 5 
recombination (7). The minimal recognition sequences for efficient TrwC-mediated 6 
recombination show different requirements at each oriT locus: a core 17 bp 7 
sequence is sufficient to host efficient recombination in locus 1, while an additional 8 
183 bp sequence is required at locus 2 (7), with the nic site located 3´ to locus 1. 9 
The recombination reaction is strictly dependent on the nicking and strand-10 
transferase abilities of TrwC, since a mutation in the two catalytic tyrosine residues 11 
completely abolished recombination (10). However, the relaxase domain alone was 12 
not sufficient to catalyze recombination; the recombinase domain has been 13 
assigned to the N-terminal 600 residues of TrwC (7). 14 
 Fig. 1b shows the R388 oriT sequence requirements for different TrwC 15 
activities. The common 17 bp core sequence comprises a highly specific sequence 16 
termed the nic site, where the scissile phosphate lies, and a 5’ region involving the 17 
recognition hairpin formed by an inverted repeat, IR2 (17). This is the essential core 18 
sequence required in vivo for both conjugal mobilization (33) and site-specific 19 
recombination (7). When the distal half of IR2 is removed, TrwC binding affinity is 20 
decreased only three fold and TrwC-mediated in vivo site-specific recombination is 21 
slightly affected (7). In contrast, the sequence 6+2 is absolutely required for TrwC 22 
binding, single-strand nicking and strand transfer reactions (33). Similar results 23 
were reported for the related TraI relaxase of the F plasmid (46), where mutations 24 
affecting the nucleotides immediately adjacent to the nic site had a strong 25 
detrimental effect on conjugation.  26 
 Once TrwC enters the recipient cell it is fully active, as shown by 27 
complementation of a trwC-deficient mutant in the recipient (10). Notably, TrwC 28 
can also catalyze integration of a conjugatively transferred oriT-containing molecule 29 
 5 
into a recipient dsDNA oriT target (10). To our knowledge, this ability of TrwC to act 1 
as a site-specific integrase is unique amongst relaxases; even the related F TraI 2 
protein cannot catalyze a similar reaction (7). Protein VirD2 of Agrobacterium 3 
tumefaciens, functionally related to conjugative relaxases, has been postulated to 4 
reach the recipient plant cell, where it directs nuclear import of the transferred DNA 5 
and aids T-DNA integration into the plant genome, preserving the integrity of the T-6 
DNA 5´end (34). However, this integration is not site-specific. In addition to VirD2, 7 
conjugative relaxases TraI and MobA from plasmids RP4 and RSF1010, 8 
respectively, have been localised within the nucleus of human cultured cells (40). 9 
However, integration assays in plants showed a specific deficiency of MobA in aiding 10 
genomic integration of the transferred DNA (2). 11 
 Given the observed capacity for bacterial conjugation to transmit DNA to 12 
mammalian cells, this feature of TrwC as a site-specific integrase upon entering the 13 
recipient cell suggests a potential biotechnological use of TrwC as an engineering 14 
integrase delivered in vivo by conjugation together with the transferred DNA (29). 15 
There are many prokaryotic recombinases used for genetic manipulation in 16 
mammals, but for most of them their target cells need to be modified in advance by 17 
addition of the recombinase target sequence to their genomes (42). In this work, 18 
we show that TrwC catalyzes recombination between its cognate oriT and human 19 
sequences closely resembling the nic site. We also address TrwC nuclear targeting, 20 
since a recombinase must target the nucleus in order to work efficiently in 21 
eukaryotic cells. By random mutagenesis we obtain a full-length TrwC mutant 22 
targeting the nucleus which is fully functional in conjugation and recombination.23 
 6 
 MATERIALS AND METHODS 1 
 2 
 Bacterial strains, plasmids and growth conditions. E.coli strain DH5α 3 
(16) was used as a host for the recombination assays. For mating assays, strains 4 
D1210 (38) and DH5α were used as donors and recipients, respectively. Plasmids 5 
used in this work are listed in Tables 1 and 2. Luria-Bertani broth was used for 6 
bacterial growth, supplemented with agar for solid culture. Selective media included 7 
antibiotics at the following concentrations: ampicillin (Ap), 100 µg/ml; 8 
chloramphenicol (Cm), 25 µg/ml; kanamycin (Km), 25 µg/ml; nalidixic acid (Nx), 9 
20 µg/ml; streptomycin (Sm), 300 µg/ml; trimethoprim (Tp), 20 µg/ml.  X-Gal was 10 
supplied at a concentration of 60 µg/ml. 11 
 12 
 Plasmid constructions. Plasmids were constructed using standard 13 
methodological techniques (39). Restriction enzymes, Shrimp Alkaline Phosphatase, 14 
T4 DNA ligase and T4 polynucleotide kinase were purchased from Fermentas. Vent 15 
polymerase was purchased from New England Biolabs. DNA sequences of all cloned 16 
PCR segments were determined. Oligonucleotides used in the amplification of 17 
human sequences were designed using the Primer3:WWW primer tool 18 
(http://biotools.umassmed.edu/bioapps/primer3_www.cgi (37)) setting an 19 
annealing temperature of 60 °C and 400 bp product size. Oligonucleotide 20 
hybridisation was performed as described (7). 21 
 Table 2 includes the details of how each plasmid was constructed. A brief 22 
description of each set of plasmids follows.  23 
 - All substrate plasmids for recombination assays are derivatives of plasmid 24 
pCIG1028 (7), which contains two wild-type oriT copies separated by a kanamycin-25 
resistance gene and a lacIQ repressor gene in vector pSU19. The 1-402 bp wild-26 
type sequence of oriT1 copy was substituted by the indicated mutations or human 27 
sequences. The latter were amplified from human genomic DNA obtained from a 28 
K562 leukemia cell line (ATCC). 29 
 7 
 - For intragenic relaxase-helicase complementation, different trwC 5´ 1 
terminal fragments were cloned in vector pSU19 under the control of the lactose 2 
promoter. All constructs carry the start codon at the same position with respect to 3 
the transcription/translation signals of the vector. 4 
 - Constructs to test nuclear import/export in yeast were made on vectors 5 
pNIA3b/pNEA3b (36), which carry appropriate sites to make protein fusions with 6 
LexA-Gal4AD and LexA- nuclear localization signal (NLS)-Gal4AD, respectively. 7 
pCMS5 carries a NLS at the C-terminus of TrwC; the oligonucleotide used to amplify 8 
trwC added a sequence coding for the peptide GKKGR just before the stop codon. 9 
To construct NLS-TrwC derivatives, oligonucleotides including the coding sequence 10 
for the SV40 NLS were hybridized and 5’ phosphorylated with T4 polynucleotide 11 
kinase. Resulting fragment was cloned into the BamHI site of plasmid pCMS9 12 
(pNIA:trwC). Two constructs were selected: pMTX719 contains five inserts that 13 
coded for NLS sequences in direct orientation and a last one in the opposite 14 
orientation, without affecting the trwC reading frame; pMTX720 carries 3 copies of 15 
the insert, two of them in the sense orientation, and the middle one in opposite 16 
orientation. To obtain a construct with a single NLS fused to the N-terminus of 17 
TrwC, pMTX719 was digested with BamHI and religated, obtaining pMTX726. 18 
Construction of pLA44 is detailed in the “Random mutagenesis” section below. 19 
Plasmid pLA66 was constructed from pLA44 as indicated in Table 2 to separate 20 
mutations present in pLA44.  21 
- For immunofluorescence analysis, trwC and derivatives were subcloned 22 
into the pCEFL expression vector (43) and expressed from the eukaryotic promoter 23 
elongation factor 1α (EF1α). 24 
 25 
 TrwC binding assays. Binding of TrwC-N293 to oligonucleotides was 26 
determined by an electrophoresis mobility shift assay as previously described (17). 27 
Oligonucleotides used were either R388 (25+8) or those containing the homologous 28 
human sequences shown in Fig. 2a. The 25+8 nomenclature refers to the 25 29 
 8 
nucleotides 5’ and 8 nucleotides 3’ to the nic site. 1 nM 5’-labelled (25+8) 1 
oligonucleotides were incubated with 0-20 nM TrwC-N293 purified as described (17) 2 
in the presence of 1 µM competitor oligonucleotide (a mixture of 3 unlabeled 3 
unspecific oligonucleotides). 4 
 5 
 DNA strand transfer assays. Oligonucleotides were 5’-labelled and strand-6 
transfer assays were performed as described (14). Assays contained 250 nM cold 7 
“donor” oligonucleotide R388(12+18) 5’- TGCGTATTGTCT/ATAGCCCAGATTTAAGGA 8 
-3’ (the slash indicates the R388 nic site according to (31)), 50 nM of the indicated 9 
“acceptor” (25+8) labelled oligonucleotides and 500 nM TrwC-N293 protein. Gels 10 
were scanned on a Molecular Imager FX system and strand-transfer products were 11 
quantified using “Quantity One” software (BioRad) and expressed as the percentage 12 
of the total label in each lane. 13 
 14 
 Recombination assays. Intramolecular recombination was tested as 15 
described (7). Briefly, the substrate plasmid (pCIG1028 or its derivatives) carries 16 
two copies of the R388 oriT. Recombination between the two copies induces 17 
expression of the downstream lacZα gene. A plasmid coding for TrwAC under the 18 
regulation of the trwA promoter was used as a helper plasmid. A plasmid coding for 19 
TrwA only was used as helper in the negative control. To test the recombination 20 
activity of TrwC derivatives in pNIA or pCEFL, plasmid pCIG1030, as pCIG1028 but 21 
coding also for trwA, was used as a substrate (7). The substrate and helper 22 
plasmids were introduced into the lacZ∆M15 strain DH5α and plated on selective 23 
media with X-gal. Recombination activity is estimated by the number and size of 24 
blue sectors in bacterial colonies. 25 
 26 
 Mating assays. Standard mating assays were performed as described (14). 27 
E. coli D1210 donor cells contained plasmid pSU1445, a TrwC deficient R388 28 
mutant, which was complemented with plasmids coding for TrwC derivatives in 29 
 9 
trans. For the relaxase-helicase complementation assays, a combination of 1 
compatible plasmids coding for C-terminal and N-terminal domains of TrwC was 2 
used to complement the transfer deficiency of plasmid pSU1445. Mating assays 3 
were performed in the presence or absence of IPTG, and no significant differences 4 
were found (data not shown). A plasmid coding for wild-type TrwC was used as a 5 
positive control and the corresponding empty vector was assayed as a negative 6 
control in all cases. 7 
 8 
 Immunofluorescence assays. Human embryonic kidney 293T cells were 9 
maintained in DMEM supplemented with 10% fetal calf serum. 6x105 293T cells 10 
were placed in 10 ml DMEM on glass coverslips and grown for 48h. Cells were 11 
transfected with 7 µg DNA + 14 µl JetPei (Genycell). After 24h, cells were fixed and 12 
permeabilized with methanol for 10 min at -20 °C, and immunostaining was 13 
performed as previously described (44). Cells were successively incubated with 14 
primary anti-TrwC antibody (15) (3h incubation at RT) and secondary FITC-15 
conjugated goat anti-rabbit antibody (Jackson Laboratories), both used at a 1:100 16 
dilution. Coverslips were mounted with anti-fading mounting medium Vectashield 17 
(Vector Laboratories) with 4′,6-diamidino-2-phenylindole (DAPI) to visualize the 18 
nucleus. Cell samples were examined using a Zeiss Imager M1 fluorescence 19 
microscope. 20 
 21 
 Nuclear import/export assays. Nuclear import/export assays in yeast 22 
were done as described (36). The Saccharomyces cerevisiae strain L40 (22) 23 
contains HIS and lacZ genes which are expressed upon binding of the LexA-Gal4AD 24 
transcriptional regulators. The pNIA vector codes for a LexA-Gal4AD fusion to which 25 
the test protein is fused; if the test protein drives the fusion to the nucleus, then 26 
the reporter genes are expressed. L40 cells were transformed by the LiAc-PEG 27 
method (12) with the pNIA/pNEA derivatives. Transformants were grown in 28 
tryptophan dropout minimal medium (DO-trp) for plasmid selection. Individual 29 
 10 
transformants were picked from these plates, grown on liquid DO-trp overnight at 1 
30ºC, and 20 µl of these cultures were streaked on DO-trp plates as positive 2 
controls and on histidine dropout minimal medium plates (DO-his) to select for HIS 3 
expression. β-galactosidase activity was assayed with X-gal on permeabilized yeast 4 
cells transferred to nitrocellulose filters, as described (22). 5 
 6 
 Random mutagenesis. Random mutagenesis of full-length TrwC was 7 
performed to select for TrwC mutants in pCMS9 entering the yeast nucleus (and 8 
thus growing in DO-his medium when introduced in yeast strain L40). Mutations 9 
were introduced by mutagenic PCR using the GeneMorph II Random Mutagenesis 10 
Kit (Pharmacia) following the manufacturer´s recommendations. We adjusted the 11 
reactions to obtain 0-3 mutations per kb. Template DNA was pCMS9. 12 
Oligonucleotides used were GGCTGGCGGTTGGGGGTTA, annealing in lexA towards 13 
the beginning of trwC, and ACCGAATTCACCTTCCGGCCTCCATGCCGCG, annealing at 14 
the end of trwC (complementary sequence to trwC stop codon shown in bold, EcoRI 15 
site underlined). Full-length trwC from the PCR amplified products was obtained by 16 
digestion with enzymes BamHI + EcoRI and cloned into the corresponding sites of 17 
pCMS10 (replacing the C774 TrwC fragment, which does not enter the yeast 18 
nucleus). In order to maximize the transformation efficiency, ligations containing 19 
the pool of mutants were first introduced in E. coli DH5α, then DNA extracted from 20 
the pool of colonies and introduced into the yeast strain in successive 21 
transformation events. About four thousands colonies were collected from DH5α, 22 
from which 34 µg DNA was extracted and used to transform competent L40 yeast 23 
cells, carrying the reporter HIS gene; 1-2µg of DNA was used per L40 aliquot. 24 
Transformations were incubated in DO-trp medium for 8 h at 30ºC, and then 1/10th 25 
plated on DO-trp plates (to calculate transformation efficiency) and the rest plated 26 
on DO-his plates. Plasmid DNA was extracted from His+ colonies using the yeast 27 
DNA extraction kit (Thermo Scientific) and introduced in DH5α for further analysis. 28 
 29 
 11 
 Western blots. In order to detect expression of TrwC fusions in yeast, cells 1 
were lysed and processed as follows. ~108 yeast L40 cells containing the pNIA 2 
derivatives were collected by centrifugation and frozen on dry ice. The pellet was 3 
then thawed at room temperature and resuspended in 300 µl of 20% Tri-chloro 4 
acetic acid (TCA). 300 µl of glass beads (425-600 microns, Sigma) were added to 5 
the resultant suspension and vortexed for 1 minute in order to lyse the cells. The 6 
extract was removed to another tube, the glass beads were washed with 300 µl of 7 
5% TCA, and this second extract was added to the first. The mixture of both 8 
extracts was centrifuged at 3000 rpm for 10 min and the pellet, containing the 9 
proteins, was resuspended in 200 µl of 1X “high pH” Laemmli buffer (ordinary 10 
Laemmli sample buffer + 150 µl 1M Tris base / 1ml buffer). Samples were boiled 11 
for 4 min and centrifuged again at 3000 rpm for 10 min. Protein samples were 12 
transferred to a new tube, discarding the pellets. 5 to 10 µl of the samples were run 13 
in 10% SDS-PAGE gels. Proteins were transferred to nitrocellulose filters which 14 
were blocked and processed as described (9). Anti-GAL4-AD antibody (Sigma-15 
Aldrich) for detection of the fusion proteins and secondary antibody (peroxidase-16 
conjugated anti-rabbit IgG from ICN) were used at a 1:10,000 dilution. Detection 17 
was performed with Supersignal kit (Pierce) and bands analyzed on a Chemi-Doc 18 
apparatus (Bio-Rad). To detect TrwC expression in human cells, 293T cells were 19 
grown and transfected as explained for immunofluorescences, centrifuged, washed 20 
with PBS, and pellets kept at -80ºC. About 106 cells were lysed with 30 µl NP40 21 
lysis buffer (150 mM NaCl, 50 mM Tris (pH 8), 20 mM NaF, 1% NP40, 1 mM 22 
Na3VO4, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 10 µg/ml aprotinin, and 23 
10 µg/ml leupeptin). 10 µl of supernatant were kept for protein quantitaion with 24 
Bradford. The rest was mixed with an equal volume of 2x Laemli buffer. 10-20 µl 25 
samples were boiled, run on SDS-PAGE, transferred and detected as above, except 26 
for the primary antibody which was anti-TrwC (15) used at a 1:10,000 dilution. 27 
 28 
 12 
 Database search. We searched for sequences homologous to the R388 nic 1 
sequence in the human genome using the “Somewhat similar sequences (blastn)” 2 
tool against the “Human genomic + transcript” database in the NCBI Blast web 3 
page (http://www.ncbi.nlm.nih.gov/blast/Blast.cgi). The search was performed 4 
using the 16 nucleotide sequence 14+2, corresponding to 14 nucleotides 5’ to the 5 
nic site + 2 nucleotides 3’ to the nic site (see Fig. 2a). 6 
 7 
 13 
 Results 1 
 2 
 TrwC mediates site-specific recombination between bacterial and 3 
human DNA sequences.  4 
 The minimal region described as a target for in vivo TrwC-mediated 5 
recombination is 14+3, at oriT1 (7). The shortest oligonucleotide that includes 6 
determinants for TrwC binding and nicking is 14+2. This segment is also enough to 7 
confer basic oriT function (17, 33) (Fig. 1b). We have searched for putative TrwC 8 
target sequences in the human genome (Fig. 2a). No perfect 14+2 matches were 9 
obtained. The search returned matches corresponding to shorter sequences 12+2 10 
(four times) and 13+1 (once). A short “core” sequence, corresponding to the 11 
sequence 10+2 was found > 50 times. We repeated the search allowing for 1 12 
mismatch within the 14+2 sequence. Seven hits were returned (Fig. 2a). All 13 
matches corresponded with either non annotated or intronic regions of the human 14 
genome. The top five human matches shown in Fig. 2a have a mismatch out of the 15 
6+2 region, critical for TrwC nicking activity. 16 
 It is predicted that TrwC binding will be a prerequisite for targeted 17 
integration. We have also shown that TrwC-mediated site-specific recombination 18 
reaction requires the nicking and strand-transfer abilities of TrwC, which can be 19 
observed in vitro on oligonucleotides containing its target sequence (32). In order 20 
to determine if the sequences found in the human genome could be targets for 21 
incoming TrwC-DNA, we performed TrwC binding and strand-transfer reactions with 22 
labelled oligonucleotides including some of the sequences shown in Fig. 2a. We 23 
selected two sequences, Hu.X and Hu.5, corresponding to 15+3 sequences carrying 24 
a single mismatch in the TrwC binding site. Both putative human targets in 25 
chromosomes X and 5 were bound by TrwC roughly with the same affinity as the 26 
R388 sequence (Fig. 2b), and both acted efficiently as acceptors of the cut R388 27 
strand donated by TrwC (Fig. 2c). 28 
 14 
 We tested several of the human sequences as TrwC targets in in vivo site-1 
specific recombination assays. We designed primers amplifying ca. 400 bp 2 
fragments from the human genome, and containing the putative target sequences. 3 
We cloned these sequences at the oriT1 locus in the recombination substrate, which 4 
carried a wild-type R388 oriT copy at the oriT2 locus. Recombination was assayed 5 
as described (7). In order to confirm the requirement of an intact nic site for 6 
recombination, we tested a substrate carrying a full-length oriT1 but carrying a 7 
mutation within the nic site, TCT/A to GAG/A. No recombination was observed (Fig. 8 
3, compare top and bottom left panels). Constructs containing the human 9 
sequences at oriT1 were compared to that containing a minimal oriT1 with the 10 
canonical 14+3 R388 sequence. The results are shown in Fig. 3. TrwC is capable of 11 
catalyzing recombination between a copy of its cognate oriT and 15+3 sequences 12 
containing a single mismatch in the TrwC binding site (top panels 3 and 4), with 13 
roughly the same proficiency as with the canonical 14+3 sequence (top panel 2). 14 
None of the constructs containing shorter consensus sequences (12+3, 13+1 or 15 
10+2) behaved as substrates for TrwC-mediated recombination (Fig. 3, bottom 16 
panels). Thus, there are a few sequences in the human genome which are targets 17 
for TrwC-mediated site-specific recombination, while sequences deviating from the 18 
consensus for more than 1 bp or not preserving the nic site are not substrates for 19 
recombination. 20 
 21 
 Localization of TrwC in human cells 22 
 In order to act as a site-specific integrase in higher organisms, TrwC must 23 
reach the nucleus by active transport. Thus, we addressed a study of TrwC 24 
localization in eukaryotic cells. Although there is no widely accepted consensus for 25 
NLS, two basic clusters of residues form the most accepted bipartite NLS: K R X(10-26 
12) K K/R X K/R (11). The second cluster on its own can function as a monopartite 27 
NLS. TrwC contains two putative NLSs in its sequence: residues 53-56 (KRFR) and 28 
171-190 (KR-X14-KRTR), both within the relaxase domain. 29 
 15 
 We cloned DNA fragments coding for the relaxase (N293), the recombinase 1 
(N600) and the helicase (C774) domains of TrwC, all known to produce stable 2 
proteins products (7, 32), and full-length TrwC, into vector pCEFL under the control 3 
of the eukaryotic constitutive promoter EF1α. We transfected human 293T cells 4 
with these plasmids and confirmed by western blot that the proteins were being 5 
stably produced in the cell (data not shown). No apparent citotoxic effect was 6 
observed in the cells after 24h of trwC overexpression. We performed 7 
immunofluorescence microscopy to show the cellular distribution of each TrwC 8 
domain (Fig. 4). The relaxase and recombinase domains of TrwC (N293 and N600) 9 
located preferentially to the nucleus, while the C-terminal helicase domain was 10 
cytoplasmic, suggesting that the putative NLS were functional. However, the 11 
localization of full-length TrwC was clearly cytoplasmic. 12 
 13 
 Nuclear import/export assays in yeast 14 
 In order to corroborate the above results and to try to understand why full-15 
length TrwC does not localize to the nucleus while shorter N-terminal fragments do, 16 
we have used a yeast-based genetic assay to look for nuclear import/export signals 17 
(36). In the import assay, test proteins are fused to LexA-Gal4AD; if the test 18 
protein enables nuclear import, LexA-Gal4AD turns on reporter genes in the yeast 19 
strain L40, which are detected by expression of beta-galactosidase and/or growth in 20 
DO-his plates. We cloned DNA fragments coding for the different TrwC domains into 21 
the pNIA vector. To verify that the fusion protein LexA-Gal4AD-TrwC was 22 
functional, we confirmed that plasmid pCMS9 (pNIA::trwC) efficiently 23 
complemented plasmid pSU1445 (R388 TrwC-) with a similar transfer frequency as 24 
a plasmid coding for wild type TrwC (Table 3a). We transformed the constructs 25 
into L40 yeast cells and performed western blots using anti-Gal4AD antibody; the 26 
fusion proteins were detected in comparable amounts (data not shown). Controls 27 
for the import assay were proteins VirD2, which enters yeast and animal nuclei, and 28 
VirE2, which enters only the plant cell nucleus (18, 23). Results (Fig. 5) indicate 29 
 16 
that the relaxase and recombinase domains of TrwC enter the nucleus, since they 1 
drive the fused LexA-Gal4AD to their nuclear targets, leading to expression of HIS 2 
and growth on DO-his plates, while growth was not observed with either the fused 3 
helicase domain or full length TrwC, correlating with the results obtained in human 4 
cultured cells. 5 
 The cytoplasmic localizaton of TrwC could be due to the lack of a functional 6 
NLS, but this is surprising considering that the N-terminal derivatives locate to the 7 
nucleus. Another option would be the presence of a sequence acting as a nuclear 8 
export signal (NES) within the helicase domain of the protein, which would redirect 9 
the protein back into the cytoplasm. An analysis of the TrwC sequence using 10 
NetNES (CBS, Technical University of Denmark), which predicts leucine-rich nuclear 11 
export signals (NES) in eukaryotic proteins (25) 12 
(http://www.cbs.dtu.dk/services/NetNES/), rendered no putative NES candidates; 13 
however, there is no general consensus for NES, since export pathways other than 14 
the CMR1-mediated are known to exist (20). We performed the related yeast 15 
nuclear export assay (36), implemented to detect the reverse protein transport into 16 
the cytoplasm. To this end, the pNEA vector, containing a NLS fused to LexA-17 
Gal4AD, was used. By default, there will be nuclear localization of the 18 
transcriptional activators and HIS expression. Fusion of a NES expressing protein 19 
would result in the transport of the protein back into the cell cytoplasm and lack of 20 
expression of the reporter gene. We cloned both full-length TrwC and the helicase 21 
domain C774 in this plasmid. We checked that pCMS15 (pNEA:trwC) fully 22 
complemented the R388 TrwC deficient plasmid in conjugation (Table 3). The 23 
results (Fig. 5b, right panels) show that fusion to the whole length TrwC protein 24 
resulted in growth, meaning that the NLS from the vector targeted the fusion 25 
protein to the nucleus, where it remained; while fusion to the helicase domain 26 
impedes growth in DO-his plates, meaning this domain is driving the fusion protein 27 
out of the nucleus. Thus, it appears that the localisation of TrwC could be at 28 
 17 
equilibrium between the nucleus (driven by the NLS in the relaxase domain) and 1 
the cytoplasm (driven by a NES present in the helicase domain). 2 
 3 
 Intragenic complementation of TrwC 4 
 N600, the recombinase domain of TrwC, enters the nucleus of yeast and 5 
human cells and remains stably within it. From the point of view of its possible 6 
application as an integrase for mammalian genomic engineering, it would be 7 
interesting to see whether N600 can be delivered to the recipient cell in vivo. If 8 
N600 can be delivered to recipient bacteria by conjugation, it can be assumed that 9 
it will be also delivered to recipient human cells by conjugation as described 10 
(Waters, 2001). 11 
 We know that C-terminal deletions of TrwC are not functional in conjugation. 12 
However, it was published elsewhere (32) that, when co-expressed in the donor 13 
bacteria, a relaxase fragment (N348) and the helicase domain C774 of TrwC could 14 
complement each other functionally to substitute TrwC in conjugation, with a 15 
frequency 104 lower than the wild type protein. This N348 fragment is, however, 16 
rather unstable (7). We assayed the N600 fragment, together with other TrwC 17 
fragments known to be stable, N293 and N450 (7), for their capacity to 18 
complement an R388 TrwC deficient plasmid in conjugation in the presence of the 19 
helicase domain. Results in Table 3b indicate that larger fragments N450 and N600 20 
can functionally complement the helicase with the same efficiency as the relaxase 21 
fragment N293. It is possible that the N-terminal domain contains part of the 22 
secretion signal that would allow the protein to be delivered through the T4SS into 23 
the recipient cell, but, as shown for most T4SS, the main determinant for substrate 24 
recognition could reside in the C-terminus (4). Hence, N600 can be transferred to a 25 
recipient cell by conjugation if the helicase domain is provided in the donor cell, 26 
albeit with very low efficiency. 27 
  28 
 TrwC mutants which enter the nucleus 29 
 18 
 Since the recombinase domain of TrwC targets efficiently the human nucleus 1 
but can be transferred with very low efficiency by conjugation, it would be desirable 2 
to obtain a full-length TrwC protein which locates to the nucleus. The results from 3 
the yeast nuclear import/export assays suggested that a NES in the C-terminal 4 
domain of TrwC was responsible for the cytoplasmic localization of the protein. We 5 
reasoned that we could target TrwC to the nucleus in two ways: by adding extra 6 
NLS or by getting rid of the NES.  7 
 We constructed pNIA:TrwC derivatives carrying either an extra NLS at the C-8 
terminus, or several NLS at its N-terminus by addition of oligonucleotides coding for 9 
the peptide IPKKKRKV in phase with trwC (see section “Plasmid constructions” in 10 
M&M, and Table 2). Cloning of the insert gave rise to constructs containing one, 11 
two, or five NLS, in frame with the N-terminus of TrwC. By western blot, we 12 
checked that NLS-TrwC levels were similar to wild-type, except for the construct 13 
with five NLS, which was not detected (not shown) and thus we did not use it 14 
further. All plasmids complemented R388 (TrwC-) with high efficiency (Table 3a). 15 
These TrwC derivatives were also tested for their ability to catalyze site-specific 16 
recombination. As can be observed in Fig. 6a, the LexA-Gal4AD-TrwC fusion 17 
protein is recombination proficient (top panel 1), and the addition of a NLS to the 18 
C-terminus of TrwC does not affect its recombination capacity (compare top panels 19 
1 and 3; 100% colonies with blue sectors); however, addition of NLS to the N-20 
terminus of TrwC affects its recombinase activity (Fig. 6a, bottom panels), from a 21 
mild effect when a single NLS is added (more than 70% colonies showing blue 22 
sectors, albeit smaller than in wild-type), to a stronger effect with two N-terminal 23 
additional NLS (about 40% colonies showing small blue sectors). When these 24 
plasmids were introduced into L40 yeast cells to test their cellular localization, we 25 
found that none of them showed nuclear localization, according to the lack of 26 
growth in DO-his plates (Fig. 6b, and data not shown). 27 
 Our second strategy was to obtain a TrwC mutant in the NES sequence, 28 
which would show nuclear localization, while probably maintaining its function in 29 
 19 
conjugation and recombination. We performed random mutagenesis on plasmid 1 
pCMS9 (pNIA:trwC), selecting for mutants which grew in DO-his plates, as 2 
explained in M&M. In total, out of about 70,000 colonies screened, we obtained six 3 
His+ colonies. 3 out of the six plasmids had no trwC insert, so they represented 4 
recircularized pNIA3b molecules (which code for a LexA-Gal4AD fusion that enters 5 
the nucleus by passive diffusion; (36)). The other three constructs were introduced 6 
in E. coli DH5α harbouring pSU1445, a TrwC-deficient R388 derivative, to test TrwC 7 
function. Two of them were transfer-negative, and were no longer characterized. 8 
The remaining construct, named pLA44, complemented pSU1445 almost to the 9 
same level as pCMS9 (Table 3a). The His+ phenotype of pLA44 was confirmed and 10 
compared to that of TrwC; it can be observed that the mutant protein allows 11 
growth on DO-his plates as the positive control VirD2 (Fig. 6b). We also checked its 12 
recombination activity: it can be observed (Fig. 6a, top panel 2) that the mutant 13 
TrwC protein is as capable as wild-type TrwC in catalyzing oriT-oriT recombination. 14 
 The trwC insert was sequenced to determine the TrwC mutations responsible 15 
for the His+ phenotype: it carried a T to G and two G to A mutations at positions 16 
1986, 2529 and 2710 of the trwC ORF, giving rise to two silent mutations, and 17 
missense mutation Ala904-Thr in TrwC respectively; in addition, presumably due to 18 
a defective oligonucleotide molecule, a CG dinucleotide was missing at position 19 
2893 of trwC, producing a sense mutation which added to the trwC ORF a tail from 20 
the vector sequence giving rise to the extra peptide KVNSCSHGSSRSTRD after 21 
residue 964 of TrwC. In order to determine which of the two mutations was 22 
responsible for nuclear localization, a plasmid was constructed carrying only the 23 
missense mutation in TrwC (pLA66, Table 2); this protein did not enter the nucleus 24 
according to the lack of growth in DO-his plates (data not shown). 25 
 In conclusion, we have obtained a TrwC mutant which is fully proficient in 26 
conjugation and recombination and targets the nucleus, which will be presumably a 27 
useful biotechnological tool for genomic engineering of human cells.28 
 20 
 Discussion  1 
 2 
 We previously reported that protein TrwC of the conjugative plasmid R388 is 3 
capable of promoting site-specific recombination between short oriT sequences (6, 4 
7), and also to catalyse site-specific integration upon conjugative transfer into a 5 
resident oriT copy (10). In this work we describe the ability of TrwC to mediate 6 
recombination on specific putative human target sequences, while discriminating 7 
amongst more frequent ubiquitous sequences. We also report the competence of 8 
TrwC recombinase domain to enter the human nucleus, and the possibility to 9 
transport this domain to the recipient cell when complemented intragenically with 10 
the helicase domain of the protein in conjugation assays. Finally, we succeed in 11 
obtaining a full-length TrwC mutant which targets the nucleus while it maintains its 12 
function in conjugation and recombination. Overall, these results emphasize the 13 
features of TrwC as a site-specific integrase that could be of potential 14 
biotechnological use for the genetic manipulation of human cells. 15 
 TrwC is structurally related to AAV-Rep protein (17, 21), which catalyzes the 16 
integration of the single-stranded viral genome into a unique human sequence 17 
homologous to the viral origin of replication, containing the 16-bp Rep binding motif 18 
and the 6-bp nicking site (26). In a similar way, TrwC could catalyze the integration 19 
of incoming ssDNA into target sites present in the genome of the recipient cell; 20 
such putative targets would be short DNA sequences resembling the R388 nic site. 21 
We searched the human genome database and we found no matches containing the 22 
precise R388 14+2 sequence. Sequences 12+3 or 13+1 were not targets for TrwC 23 
mediated recombination with a wild type R388 oriT copy (Fig. 3, bottom panels), 24 
underscoring the sequence specificity of TrwC. A substrate containing either 25 
sequences 15+3 (-7) on chromosome X, or 15+3 (-10) on chromosome 5, with the 26 
mismatch lying outside of the essential nicking region, yielded similar 27 
recombination efficiency as R388 14+3 sequence (Fig. 3, top panels). TrwC-28 
mediated recombination is affected by vector DNA replication and by local DNA 29 
 21 
topology (6, 7), so DNA packaging in the human genome may well affect TrwC-1 
mediated integration of foreign DNA; it has been shown that the ability of Tn7 to 2 
transpose to a putative human target site is decreased in in vitro assembled 3 
nucleosomes (24). Integration assays in human cells will be required to determine 4 
if any of the above mentioned human sequences works as a target for TrwC-5 
mediated integration of foreign DNA, and if this integration has any deleterious 6 
effect on human cell physiology; although the putative targets do not affect any 7 
known coding sequence, the Hu5 target lies in an intronic region, which could affect 8 
correct splicing of the MCC gene. 9 
 In order to integrate exogenous DNA into these specific sites of the human 10 
genome, the protein must reach the nucleus. Although the nuclear membrane is not 11 
a permanent barrier, it has been reported that addition of a NLS to an integrase 12 
increases its integration frequency in eukaryotes (8). TrwC or its functional domains 13 
were expressed in human cell lines and their localization confirmed by 14 
immunoflluorescence (Fig. 4): the relaxase and recombinase domains of TrwC 15 
showed nuclear localization, supporting the existence of a functional NLS in the N-16 
terminal domain of TrwC. Similar results were obtained in a yeast-based assay (Fig. 17 
5), where TrwC fragments were expressed fused to transcriptional regulators, thus 18 
discarding nuclear entrance by passive diffusion. However, the whole length protein 19 
showed cytoplasmic localization in both assays. The results of the yeast nuclear 20 
export assay suggested the presence of a NES-like sequence in the helicase domain 21 
of the protein (Fig. 5), which could transport TrwC back into the cytoplasm. We 22 
obtained by random mutagenesis a TrwC mutant which targets the nucleus while 23 
retaining full activity in conjugation and recombination, of potential interest for 24 
future experimentation on TrwC activity as a site-specific integrase in mammals. 25 
The mutant carried a missense A904T mutation close to the C-terminus, and a 26 
sense mutation which added a peptide tail to the protein KVNSCSHGSSRSTRD. 27 
Since a plasmid carrying only the A904T mutation did not enter the nucleus, the 28 
 22 
added tail is responsible for nuclear localization of TrwC, presumably by affecting a 1 
NES not belonging to any defined consensus.  2 
Addition of NLS sequences to either the N- or the C-terminus of TrwC did not 3 
target the protein to the nucleus. Curiously, the progressive addition of NLS to the 4 
N-terminus of the protein did not alter its function in conjugation, but affected its 5 
recombinase activity (Table 3a and Fig. 6). This is the first time that recombinase 6 
activity can be separated from TrwC function in conjugation. This different effect 7 
could be due to a higher demand of TrwC for recombination than conjugation; in 8 
conjugation, we have observed repeatedly that very small amounts of TrwC are 9 
enough to efficiently mobilize DNA. Fusion proteins could alter TrwC function and 10 
yet this would not affect conjugation due to the high number of TrwC molecules in 11 
the cell, while recombination would be affected. A similar effect has been recently 12 
reported for conjugative coupling protein TrwB (9): to observe the effect of certain 13 
TrwB mutants in conjugation, a TrwB-limiting mating assay had to be used; 14 
otherwise, mild phenotypes are masked by the high number of TrwB molecules 15 
present in the cell.  16 
 Recombinases of bacterial or viral origin have been widely used for 17 
mammalian genomic modification (42). Among them, the only integrases known to 18 
work on naturally existing human targets are the TrwC-related AAV-Rep protein and 19 
integrases of the phiC31 family; these proteins pose several problems for genome 20 
modification, such as their low sequence specificity, viral limited DNA packaging 21 
capacity, or toxicity of the expression of the integrase in human cells (35). These 22 
problems could be overcome by the system we propose, based on in vivo TrwC-23 
DNA transfer to mammalian cells by bacterial conjugation (45). The obtained TrwC 24 
nuclear mutant could mediate site-specific integration of the incoming foreign DNA 25 
into specific human targets. Conjugation is a processive mechanism which imposes 26 
no limit on the DNA length that could be transferred into human cells. trwC 27 
overexpression does not seem to affect cell viability or morphology; but even more 28 
importantly, since TrwC is delivered to the recipient cell attached to the DNA, there 29 
 23 
is no need for trwC expression in the recipient cell, thus avoiding toxicity problems. 1 
And finally, conjugative relaxases show high sequence specificity. In the future, a 2 
bank of mutant relaxases could be obtained which target different sequences; in 3 
fact, the first such TrwC mutants have already been obtained (13). We are also 4 
addressing a mutagenesis analysis of TrwC-related relaxases to obtain 5 
recombinase-proficient mutants which could be similarly used on other possible 6 
targets present in human and mammalian genomes.7 
 24 
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Figure legends 1 
 2 
 Figure 1. Functional dissection of TrwC and its target oriT sequence. a) Map 3 
of the TrwC protein showing its functional domains. Tra, transfer (functionality in 4 
conjugation). Rel, in vitro relaxase activity. Rec, in vivo site-specific recombinase 5 
activity. Hel, DNA helicase activity. Dim, dimerization ability. Data taken from (32) 6 
and (7). b) DNA sequence of the central R388 oriT region (coordinates 201 to 173 7 
from (27)). The inverted repeat IR2 is indicated with arrows. Horizontal bars show 8 
the minimal sequence requirements for different TrwC activities: bind, in vitro TrwC 9 
binding on oligonucleotides; nic, in vitro TrwC nicking and strand-transfer activity 10 
on oligonucleotides; recombination, in vivo TrwC-mediated site-specific 11 
recombination; transfer, conjugal mobilization (data taken from (33) and (7)).  12 
 13 
 Figure 2. Putative TrwC targets in the human genome. a) DNA sequences 14 
resembling the R388 nic site. The minimal region required for TrwC activity is 15 
highlighted in bold. The nic site is indicated by a slash. Arrows show the inverted 16 
repeat recognised by TrwC. Nucleotides identical to the R388 sequence are shown 17 
in capital letters. The minimal target corresponds to the 173-190 oriT sequence 18 
present in plasmid pCIG1073. The mutation altering the R388 nic site in pCIG1110 19 
is shown below the wild-type R388 sequence. Below, the seven human sequences 20 
including the R388 14+2 sequence with a single mismach are shown, together with 21 
shorter sequences mentioned in the text. Sequences are named indicating the 22 
human (Hu.) chromosome number and the homologous nucleotides 5’+3’ with 23 
respect to the nic site; mismatch position is indicated in brackets. b) TrwC binding 24 
assays on (25+8) oligonucleotides containing the sequences shown in a). The 25 
amount of TrwC-N293 protein in each assay is indicated at the bottom (in ng). 26 
Arrows point to free (grey arrow) and retarded, TrwC-bound oligonucleotide (black 27 
arrow). c) TrwC strand-transfer reactions on oligonucleotides including the indicated 28 
R388 and human sequences. Arrows point to the cut product (grey arrow) or strand 29 
 32 
transfer product (black arrow), which is quantitated at the bottom of the gel (%ST). 1 
Assays in b) and c) performed as explained in Materials and Methods. 2 
 3 
 Figure 3. Typical colonies obtained with recombination substrates 4 
containing the indicated sequences (as shown in Fig. 2a) cloned at oriT1. oriT2 5 
remains invariable, and contains the full length original R388 oriT. Recombination  6 
assays were done in DH5α strain in the presence of a plasmid coding for both TrwA 7 
and TrwC.  8 
 9 
 Figure 4. Localization of TrwC and derivatives in human cells. 10 
Immunofluorescence images of 293T cells transduced with plasmids coding for 11 
TrwC or the indicated TrwC segments. Images are shown at 40x. 12 
 13 
 Figure 5. Yeast nuclear import/export assays. a) Scheme of the yeast 14 
nuclear import assay. The test protein (green circle) is fused to transcriptional 15 
regulators which turn on reporter genes if driven into the nucleus, thus allowing 16 
expression of HIS3 and lacZ. Selection is illustrated in the right panels: HIS3 17 
expression allows growth in histidine-deficient medium (-His) and lacZ is monitored 18 
by β-galactosidase activity in cells transferred to nitrocellulose filters with X-gal 19 
(NC+X-gal). b) Results of the nuclear import (left two panels) and export (right two 20 
panels) assay with TrwC and derivatives. Numbers on plates in both a) and b) are 21 
as follows: 1, pNIA:VirD2; 2, pNIA:E2; 3, pNIA:N293; 4, pNIA:C774; 5, 22 
pNIA:TrwC; 6, pNIA:N600; 7, pNEA:VirE2; 8, pNEA:TrwC; 9, pNEA:C774. 23 
 24 
 Figure 6. TrwC mutants for nuclear targeting. a) Recombination assays. 25 
DH5α cells containing the recombination substrate pCIG1030 (including trwA) and 26 
the plasmid coding for the indicated TrwC fusion derivative were plated on X-gal 27 
containing selective media. TrwC* refers to the TrwC mutant coded by plasmid 28 
pLA44. b) Yeast nuclear import assays (as in Fig. 5). C+ and C- refer to pNIA:VIrD2 29 
 33 
and pNIA:VirE2, respectively. Numbers on plates indicate: 1, pNIA:TrwC; 2, 1 
pNIA:TrwC* (TrwC mutant coded by pLA44); 3, pNIA:TrwC-NLS; 4, pNIA:NLS(x2)-2 
TrwC.3 
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Table 1. Published plasmids used in this work. 
 
 
Plasmid Description      Reference 
______________________________________________________________ 
 
pCEFL  eukaryotic expression vector   (43) 
pCIG1028  oriT1-oriT2 recombination substrate  (7) 
pCIG1030  As pCIG1028 + trwA     (7) 
pCIG1051 pET3a::trwC(N450)     (7) 
pCIG1073 As pCIG1028 with oriT1(173-190)   (7) 
pCIG1099 pET3a::trwC(N600)     (7) 
pCMS13 pKK223-3::oriT(63-330)mut1   (7) 
pET:trwA pET3a::trwA      (7) 
pET3:trwAC pET3a:PtrwA-trwA-trwC    (10) 
pET29:trwAC pET29c:PtrwA-trwA-trwC    (10) 
pNEA3b lexA-SV40NLS-gal4AD fusion   (36) 
pNEA:VirE2 control - for nuclear export    (36) 
pNIA3b lexA-gal4AD fusion     (36) 
pNIA:VirD2 control + for nuclear import   (36) 
pNIA:VirE2 control - for nuclear import    (36) 
pSU19  cloning vector     (1) 
pSU1445  R388:Tn5tac1 in trwC    (28) 
pSU1483 pKK223-3::trwC     (15) 
pSU1534 pHG327::trwC(C774)    (32) 
pSU1600 pET3a::trwC(N293)     (7) 
pSU1621 pET3a::trwC      (17) 
______________________________________________________________________ 
 
1 Mutation affecting the nic site (TCT/A to GAG/A change)
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Table 2. Bacterial plasmids constructed in this work. 
               Construction 
1
 
       ______________________________________________________________________________ 
Plasmid Description    Vector  Insert       Digestion/oligonucleotides (5´-3´) 
__________________________________________________________________________________________________________________________ 
 
Recombination substrates  
pCIG1110 oriT1(63-330mut 2)   pCIG1028 pCMS13  AACTCTAGAACCCAATGCGCATAGCG 
            AACAAGCTTCCTCTCCCGTAGTGTTAC 
pCIG1116 oriT1 HuX 15+3(-7) 3  pCIG1028 human DNA  CCATCTAGATTAGACACAGGCTCTACTCACACAG 
            TACAAGCTTAAAAATTCAACACAGCCTCTAAGTG 
pCIG1117  oriT1 Hu5 15+3(-10) 3  pCIG1028 human DNA  CCATCTAGATCTAAGATGCAGTAAGATCCCAGAC 
            TACAAGCTTTCAAGATTAGTGAGCAAGAAATGTG 
pCIG1122  oriT1 Hu18 (10+2) 3   pCIG1028 human DNA  CCATCTAGACCTTGAACCTATTCTGCCCATA 
            TACAAGCTTTCAAGGCTCTTGATGTTTGAGA 
pCIG1126  oriT1 Hu5b (13+1) 3   pCIG1028 human DNA  CCATCTAGAAGCTATGCACAACAGCATGG 
            TACAAGCTTAATCCCAATATTTGACCACCA 
pCIG1127  oriT1 Hu7 (12+3) 3   pCIG1028 human DNA  CCATCTAGACCTGGCGATAGAGCAAGACT 
            TACAAGCTTCTGACCACCTGCTCCAAAAT 
 
Plasmids for intragenic complementation assays       
pCIG1070  pSU19::TrwC (N450)  pSU19  pCIG1051  XbaI / BamHI 
pCIG1086  pSU19::TrwC   pSU19  pSU1621  XbaI / BamHI     
pCIG1103  pSU19::TrwC (N600)  pSU19  pCIG1099  XbaI / BamHI 
pLA35   pSU19::TrwC (N293)   pSU19  pSU1600  XbaI / BamHI 
 
Plasmids for yeast nuclear import/export assays  
pCIG1133 pNIA::TrwC (N600)   pNIA3b pSU1621  ACCGGATCCCGATGCTCAGTCACATGGT 
            CCAGAATTCACTCGATGGCCTTGGTTTG 
pCMS2 pNIA::TrwC (N293)   pNIA3b pSU1621  ACCGGATCCCGATGCTCAGTCACATGGT 
            ACCGAATTCAGCTGAAATCTATGCCGAG 
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               Construction 
1
 
       ______________________________________________________________________________ 
Plasmid Description    Vector  Insert       Digestion/oligonucleotides (5´-3´) 
__________________________________________________________________________________________________________________________ 
 
pCMS5 pNIA::TrwC-NLS   pNIA3b pSU1621  ACCGGATCCCGATGCTCAGTCACATGGT 
            CCAGAATTCTACCTACCTTTCTTTCCGGCCTCCATGCC 
pCMS9 pNIA::TrwC    pNIA3b pSU1621  ACCGGATCCCGATGCTCAGTCACATGGT 
            ACCGAATTCACCTTCCGGCCTCCATGCC 
pCMS10 pNIA::TrwC (C774)    pNIA3b pSU1621  CCAGGATCCTTGGAGCCGTCTATAAC 
            ACCGAATTCACCTTCCGGCCTCCATGCC 
pCMS15 pNEA::TrwC    pNEA3b pCMS9  ACCGGATCCCGATGCTCAGTCACATGGT 
            CCACTCGAGACCTTCCGGCCTCCATGCC 
pCMS16 pNEA::TrwC (C774)   pNEA3b pCMS10  CCAGGATCCTTGGAGCCGTCTATAAC 
            CCACTCGAGACCTTCCGGCCTCCATGCC 
pLA44   pNIA::TrwC* 4   pCMS10 pCMS9  mutagenic PCR 5 
            GGCTGGCGGTTGGGGGTTA 
            ACCGAATTCACCTTCCGGCCTCCATGCCGCG 
pLA66  pNIA::TrwC (A904T)   pCMS10 pLA44   ACCGGATCCCGATGCTCAGTCACATGGT 
            ACCGAATTCACCTTCCGGCCTCCATGCC 
pMTX719 pNIA::NLS(x5)-TrwC  pCMS9 oligos 6  GATCCCCAAGAAGAAACGGAAGGT 
            GATCACCTTCCGTTTCTTCTTGGG 
pMTX720  pNIA::NLS(x2)-TrwC  pCMS9 oligos 6  GATCCCCAAGAAGAAACGGAAGGT 
            GATCACCTTCCGTTTCTTCTTGGG 
pMTX726 pNIA::NLS-TrwC   pMTX719 none   BamHI and religation 
 
Plasmids used for immunofluorescences  
pLA14  pCEFL::TrwC    pCEFL  pET29:trwAC  ACCAAAGCTTATGCTCAGTCACATGGTATT 
            ACCAGGATCCTTACCTTCCGGCCTCCA 
pLA27  pCEFL::TrwC (N293)   pCEFL  pCMS3  BamHI / EcoRI 
pLA28  pCEFL::TrwC (N600)   pCEFL  pCIG1133  BamHI / EcoRI 
pLA29  pCEFL::TrwC (C774)   pCEFL  pCMS10  BamHI / EcoRI 
__________________________________________________________________________________________________________________________ 
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1
 First column lists the vector plasmids; second column lists the plasmids from which the inserts were obtained, and third column 
indicates either the restriction enzymes used for cloning, or the oligonucleotides used for PCR amplification of the desired fragment, with 
the restriction sites underlined. 
 
2 Mutation affecting the nic site (TCT/A to GAG/A change) 
 
3 
Human sequences in the indicated human chromosomes (Hu X, 5, 18, or 7). n + n’ indicates the extend of the consensus 
sequence around the nic site; variations from consensus are indicated in brackets (see text for details and nomenclature). 
 
4
 TrwC*: TrwC mutant obtained by random mutagenesis. It carries missense mutation A904T and the additional peptide 
KVNSCSHGSSRSTRD after residue 964 of TrwC.  
 
5 This PCR reaction was performed under mutagenic conditions, as described in Materials and Methods. The PCR fragment was 
digested with BamHI and EcoRI and ligated into the same sites of the pCMS10 backbone. 
6 
NLS sequences were added to the N-terminus of TrwC by oligonucleotide hybridization and insertion at BamHI site of pCMS9. 
__________________________________________________________________________________________________________________________ 
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Table 3. Transfer frequencies of R388 trwC mutant pSU1445 when 
complemented by different TrwC derivatives 1
 
 ________________________________________________________ 
Plasmids            TrwC protein     Transfer freq 2 
_________________________________________________________________________________ 
a) complementation by TrwC fusion proteins  
pSU1483      TrwC         1,0 x 10-1  
pCMS9       LexA-Gal4AD-TrwC       4,0 x 10-1  
pCMS15      LexA-NLS-Gal4AD-TrwC        6,0 x 10-1  
pCMS5      LexA-Gal4AD-TrwC-NLS       4,0 x 10-1  
pMTX720      LexA-Gal4AD-NLSx2-TrwC    1,1 x 100 
pMTX726      LexA-Gal4AD-NLS-TrwC       1,3 x 100 
pLA44       LexA-Gal4AD-TrwC mut       1,3 x 10-1 
pNIA3b      none         < 10-7 
b) relaxase-helicase intragenic complementation 
pCIG1086+pSU1534      TrwC + C774        2,1 x 10-1  
pLA35+pSU1534      N293 + C774        1,1 x 10-5 
pCIG1070+pSU1534      N450 + C774        1,1 x 10-5 
pCIG1103+pSU1534      N600 + C774        3,1 x 10-5 
pSU1534       C774         < 10-7 
____________________________________________________ 
1 Matings were performed as explained in M&M. Donor strains carried plasmid 
pSU1445 (R388 TrwC-) and the plasmid(s) indicated in the first column, which code 
for the TrwC derivatives indicated in the second column. 
2 Transfer frequencies, expressed as trasnconjugants per donor cell. Results 
represent the mean of 3-9 independent experiments. 
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